Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Asymchem Laboratories
Pharma
AstraZeneca, Hengrui, Takeda—Fierce Pharma Asia
AZ's CEO is eying innovation from China as the company plots a $1.5 billion ADC plant in Singapore. The FDA rejected a combo from Hengrui and Elevar.
Angus Liu
May 24, 2024 8:31am
Chinese CDMO Asymchem takes over former Pfizer site in UK
May 21, 2024 5:35pm
Eisai-Biogen, Astellas-Pfizer, Novartis—Fierce Pharma Asia
Sep 30, 2022 9:15am
Asymchem Labs in early planning for $697M manufacturing facility
Sep 27, 2022 9:51am
Takeda, Daiichi Sankyo, Dizal, Biden and more—Fierce Pharma Asia
Sep 16, 2022 10:15am
Asymchem completes construction at new Chinese production sites
Apr 7, 2022 9:40am
